Author： Pal Sumanta Kumar Reckamp Karen Yu Hua Figlin Robert A
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.11, 2010-11, pp. : 1355-1366
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Clinical and Marketed Proteasome Inhibitors for Cancer Treatment
Current Medicinal Chemistry, Vol. 20, Iss. 20, 2013-07 ,pp. :
The Development of MetAP-2 Inhibitors in Cancer Treatment
Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-01 ,pp. :
PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. :